Sort
50,496 grants matching “lung cancer”
SHCC MU NCORP
$802,987Thomas Lad · Hektoen Institute For Medical Research · UG1 · FY2014 · CA
Risk Stratification for COPD Exacerbations with CT Analysis and Multidimensional Trajectory Subtyping
$802,927James Ross · Brigham And Women'S Hospital · R01 · FY2024 · HL
Visual Media Influences on Adolescent Smoking Behavior (Y10-14 Renewal)
$802,573James D. Sargent · Dartmouth College · R01 · FY2011 · CA
Tissue Array Research Program
$802,520Stephen Hewitt · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Color MPI as a novel method for in vivo assessment of magnetic nanoparticle dynamics and binding
$802,387Patrick Goodwill · Magnetic Insight, Inc. · R44 · FY2021 · EB
Controlling the Niche to Control Clonal Hematopoiesis
$802,301Joseph Michael Scandura · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · HL
Cellular, molecular and quantitative imaging analysis of screening-detected lung adenocarcinoma
$802,247Pierre P Massion · Vanderbilt University Medical Center · U01 · FY2016 · CA
p53, Aging, and Cancer
$802,217Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis
$802,099Chetan Seshadri · University Of Washington · R01 · FY2024 · AI
Chemoattractant-based immunotherapeutics to modulate immune and cancer cells
$802,045Arya Arya · Aging · Z01 · FY2007 · AG
Reprograming the tumor microenvironment to overcome multiple primary and acquired immune resistance mechanisms in ovarian cancer
$802,002Kunle O Odunsi · Roswell Park Cancer Institute Corp · U01 · FY2019 · CA
Molecular Biology of the Metastatic Phenotype
$801,797Patricia Schriver Steeg · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Lung Cancer
$801,730Kristy Perez · Civatech Oncology, Inc. · R44 · FY2019 · CA
ATECAR: Asian Training, Education on Cancer &Research
$801,543Temple University · U01 · FY2005 · CA
Elucidating the role of inflammation in breast cancer metastasis
$801,501Takeo Fujii · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis
$801,468Chetan Seshadri · University Of Washington · R01 · FY2021 · AI
Self-Management to Optimize Survivorship Care and Outcomes in Lung and Colorectal Cancer
$801,402Virginia Chih-Yi Sun · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Quantifying cardiovascular calcification at very old age for personalized risk classification
$801,290Kunihiro Matsushita · Johns Hopkins University · R01 · FY2017 · HL
Clonal hematopoiesis in the Women's Health Initiative
$801,184Alexander P Reiner · Fred Hutchinson Cancer Research Center · R01 · FY2020 · HL
DIETARY FACTORS IN THE ETIOLOGY OF CANCER IN SHANGHAI
$801,125University Of Southern California · R01 · FY2000 · CA
Clonal Hematopoeisis of Indeterminate Potential and Risk of Autopsy-defined Sudden Cardiac Death
$801,056Zian H Tseng · University Of California, San Francisco · R01 · FY2022 · HL
Molecular Imaging of Primary Amyloid Cardiomyopathy
$801,025Sharmila Dorbala · Brigham And Women'S Hospital · R01 · FY2019 · HL
Molecular Imaging of Primary Amyloid Cardiomyopathy
$801,025Sharmila Dorbala · Brigham And Women'S Hospital · R01 · FY2018 · HL
LKB1 tumor suppressor and human cancer
$801,002Diego H Castrillon · Ut Southwestern Medical Center · U01 · FY2011 · CA
EFFECT OF A MULTIPEPTIDE KRAS VACCINE IN THE PREVENTION OF PANCREATIC CANCER DRIVEN BY KRAS ONCOPROTEIN HHSN2612015000371 TORFP: 2017-E02
$800,994Ming You · Medical College Of Wisconsin · N01 · FY2017 · CA